ATS Medical, Inc. (NASDAQ: ATSI) is focused on providing novel products and services designed specifically for cardiac surgery. Over 160,000 ATS Open Pivot(R) Heart Valves have been implanted in patients around the globe. ATS’ 3f(R) brand includes multiple tissue heart valve product offerings at varying steps from market introductions and clinical trials to development projects that utilize less invasive valve replacement technology. For further information, visit the Company’s web site at www.atsmedical.com.
- 18 years ago
QualityStocks
ATS Medical, Inc. (NASDAQ: ATSI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…